Clinical Trials Directory

Trials / Unknown

UnknownNCT06219590

Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The investigators initial study opened the way for randomized trials that monitor the effects of acetylcholine (Ach) iontophoresis vasodilators on endothelial nitric oxide synthetase (NOS) to develop a transdermal treatment that is effective, free from systemic adverse effects.

Detailed description

The investigators studied endothelial-mediated microvascular blood flow in neuropathic diabetic patients to determine the association between endothelial regulation of the microcirculation and the expression of endothelial constitutive nitric oxide synthetase (NOS). As a result, the nerve fibers can become damaged. Once the nerves have been damaged they cannot repair themselves. Material and methods: A group of 80 patients (male and female) diagnosed as type 2 diabetes mellitus, will be included in the study their age ranged from 40-60 years. Patients randomly will be divided into two groups: Study groups (A) 40 patients type 2 diabetes mellitus with clinically proved peripheral neuropathy. And control group (B) 40 patients with asymptomatic type 2 diabetes mellitus. They were selected from south valley university hospitals. Group (A) receive iontophoresis by acetylcholine with (15) min for three sessions per week for four weeks. Also the investigators followed up study group (A) one month of aerobic exercises in form of 15 minute walking, bicycling, or swimming, and the investigators reevaluated nitric oxide level. Group (B) received shame iontophoresis with (15) min for three sessions per week for four weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcetylcholine IontophoresisAcetylcholine Iontophoresis 15 min/ three sessions/ week for two weeks.
PROCEDUREShame Acetylcholine IontophoresisShame Acetylcholine Iontophoresis 15 min/ three sessions/ week for two weeks.

Timeline

Start date
2023-10-28
Primary completion
2024-01-20
Completion
2024-01-30
First posted
2024-01-23
Last updated
2024-01-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06219590. Inclusion in this directory is not an endorsement.